Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 3;44(10):116378.
doi: 10.1016/j.celrep.2025.116378. Online ahead of print.

Human assembloid of human blood vessel organoids with pancreatic islets improves insulin secretion over time ex vivo

Affiliations
Free article

Human assembloid of human blood vessel organoids with pancreatic islets improves insulin secretion over time ex vivo

Emily Tubbs et al. Cell Rep. .
Free article

Abstract

Pancreatic islet transplantation is a promising treatment strategy for type 1 diabetes patients; however, there are still major challenges to overcome, including vascularization. Despite a substantial need to understand the islet graft decline observed in patients 5-10 years post transplantation, clinical translation remains challenging, probably because of species-specific features and the lack of in vitro vascularized models. Here, we report results of a human assembloid composed of self-organizing 3D blood vessel organoids (BVOs) with human pancreatic islets. We demonstrate that co-culture of islets and BVOs ex vivo leads to an auto-organized assembloid (by light-sheet fluorescence microscopy) and improves insulin secretion over time (functionality assays) on 5 independent human islet donors (from 3 different hospital facilities). Taken together, this study could accelerate our understanding of type 1 diabetes and facilitate therapeutic development for type 1 diabetes patients.

Keywords: CP: Stem cell research; assembloid; blood vessel organoid; islet transplantation; pancreas; type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.P. is one of the authors of the patent application US20200199541A1 relating to blood vessel organoid generation. Furthermore, J.P. is a founder, shareholder, and chairman of the scientific advisory board of Angios Biotech, a company establishing BVOs for drug testing and vascular transplants.

LinkOut - more resources